ecg analysis version 2 0 software Search Results


ecg analysis version 2 0 software  (ADInstruments)
96
ADInstruments ecg analysis version 2 0 software
Ecg Analysis Version 2 0 Software, supplied by ADInstruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecg analysis version 2 0 software/product/ADInstruments
Average 96 stars, based on 1 article reviews
ecg analysis version 2 0 software - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
chart ecg analysis software  (ADInstruments)
96
ADInstruments chart ecg analysis software
Neonatal AAV-9 microdystrophin therapy improves the <t>ECG</t> profile in young adult mdx mice. (A) Representative serial lead II tracings from mdx, AAV microgene-treated mdx, and BL10 mice. RR, the time interval between two QRS complexes. It is inversely correlated with the heart rate. The dotted lines denote the relative position of an RR interval in BL10 mice. (B) Representative single lead II tracing from mdx, AAV microgene-treated mdx, and BL10 mice. PR, the time interval between the onset of atrial depolarization and the onset of ventricular depolarization. QT, time interval between the onset of ventricular depolarization and the end of ventricular repolarization. The dotted lines denote the approximate positions of the PR and QT intervals. (C) ECG profiles from mdx, AAV microgene-treated mdx, and BL10 mice. *Significantly different from that of mdx (p < 0.04); **significantly different from that of mdx (p ≤ 0.001). Significant differences between BL10 and AAV-treated mdx are marked for HR, PR, QTc, and cardiomyopathy index. The QRS duration and the Q amplitude showed no significant difference among BL10, mdx, and AAV-treated mdx mice. HR, heart rate; PR, PR interval; QRS, QRS duration; QTc, heart rate-corrected QT interval; Q Amp, Q amplitude in lead I; C. Index, cardiomyopathy index.
Chart Ecg Analysis Software, supplied by ADInstruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chart ecg analysis software/product/ADInstruments
Average 96 stars, based on 1 article reviews
chart ecg analysis software - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
super-ecg v2.0  (Mortara Instrument)
90
Mortara Instrument super-ecg v2.0
Neonatal AAV-9 microdystrophin therapy improves the <t>ECG</t> profile in young adult mdx mice. (A) Representative serial lead II tracings from mdx, AAV microgene-treated mdx, and BL10 mice. RR, the time interval between two QRS complexes. It is inversely correlated with the heart rate. The dotted lines denote the relative position of an RR interval in BL10 mice. (B) Representative single lead II tracing from mdx, AAV microgene-treated mdx, and BL10 mice. PR, the time interval between the onset of atrial depolarization and the onset of ventricular depolarization. QT, time interval between the onset of ventricular depolarization and the end of ventricular repolarization. The dotted lines denote the approximate positions of the PR and QT intervals. (C) ECG profiles from mdx, AAV microgene-treated mdx, and BL10 mice. *Significantly different from that of mdx (p < 0.04); **significantly different from that of mdx (p ≤ 0.001). Significant differences between BL10 and AAV-treated mdx are marked for HR, PR, QTc, and cardiomyopathy index. The QRS duration and the Q amplitude showed no significant difference among BL10, mdx, and AAV-treated mdx mice. HR, heart rate; PR, PR interval; QRS, QRS duration; QTc, heart rate-corrected QT interval; Q Amp, Q amplitude in lead I; C. Index, cardiomyopathy index.
Super Ecg V2.0, supplied by Mortara Instrument, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/super-ecg v2.0/product/Mortara Instrument
Average 90 stars, based on 1 article reviews
super-ecg v2.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
chart ecg analysis module v2.0  (ADInstruments)
90
ADInstruments chart ecg analysis module v2.0
Neonatal AAV-9 microdystrophin therapy improves the <t>ECG</t> profile in young adult mdx mice. (A) Representative serial lead II tracings from mdx, AAV microgene-treated mdx, and BL10 mice. RR, the time interval between two QRS complexes. It is inversely correlated with the heart rate. The dotted lines denote the relative position of an RR interval in BL10 mice. (B) Representative single lead II tracing from mdx, AAV microgene-treated mdx, and BL10 mice. PR, the time interval between the onset of atrial depolarization and the onset of ventricular depolarization. QT, time interval between the onset of ventricular depolarization and the end of ventricular repolarization. The dotted lines denote the approximate positions of the PR and QT intervals. (C) ECG profiles from mdx, AAV microgene-treated mdx, and BL10 mice. *Significantly different from that of mdx (p < 0.04); **significantly different from that of mdx (p ≤ 0.001). Significant differences between BL10 and AAV-treated mdx are marked for HR, PR, QTc, and cardiomyopathy index. The QRS duration and the Q amplitude showed no significant difference among BL10, mdx, and AAV-treated mdx mice. HR, heart rate; PR, PR interval; QRS, QRS duration; QTc, heart rate-corrected QT interval; Q Amp, Q amplitude in lead I; C. Index, cardiomyopathy index.
Chart Ecg Analysis Module V2.0, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chart ecg analysis module v2.0/product/ADInstruments
Average 90 stars, based on 1 article reviews
chart ecg analysis module v2.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Neonatal AAV-9 microdystrophin therapy improves the ECG profile in young adult mdx mice. (A) Representative serial lead II tracings from mdx, AAV microgene-treated mdx, and BL10 mice. RR, the time interval between two QRS complexes. It is inversely correlated with the heart rate. The dotted lines denote the relative position of an RR interval in BL10 mice. (B) Representative single lead II tracing from mdx, AAV microgene-treated mdx, and BL10 mice. PR, the time interval between the onset of atrial depolarization and the onset of ventricular depolarization. QT, time interval between the onset of ventricular depolarization and the end of ventricular repolarization. The dotted lines denote the approximate positions of the PR and QT intervals. (C) ECG profiles from mdx, AAV microgene-treated mdx, and BL10 mice. *Significantly different from that of mdx (p < 0.04); **significantly different from that of mdx (p ≤ 0.001). Significant differences between BL10 and AAV-treated mdx are marked for HR, PR, QTc, and cardiomyopathy index. The QRS duration and the Q amplitude showed no significant difference among BL10, mdx, and AAV-treated mdx mice. HR, heart rate; PR, PR interval; QRS, QRS duration; QTc, heart rate-corrected QT interval; Q Amp, Q amplitude in lead I; C. Index, cardiomyopathy index.

Journal: Human Gene Therapy

Article Title: Adeno-Associated Virus Serotype-9 Microdystrophin Gene Therapy Ameliorates Electrocardiographic Abnormalities in mdx Mice

doi: 10.1089/hum.2008.058

Figure Lengend Snippet: Neonatal AAV-9 microdystrophin therapy improves the ECG profile in young adult mdx mice. (A) Representative serial lead II tracings from mdx, AAV microgene-treated mdx, and BL10 mice. RR, the time interval between two QRS complexes. It is inversely correlated with the heart rate. The dotted lines denote the relative position of an RR interval in BL10 mice. (B) Representative single lead II tracing from mdx, AAV microgene-treated mdx, and BL10 mice. PR, the time interval between the onset of atrial depolarization and the onset of ventricular depolarization. QT, time interval between the onset of ventricular depolarization and the end of ventricular repolarization. The dotted lines denote the approximate positions of the PR and QT intervals. (C) ECG profiles from mdx, AAV microgene-treated mdx, and BL10 mice. *Significantly different from that of mdx (p < 0.04); **significantly different from that of mdx (p ≤ 0.001). Significant differences between BL10 and AAV-treated mdx are marked for HR, PR, QTc, and cardiomyopathy index. The QRS duration and the Q amplitude showed no significant difference among BL10, mdx, and AAV-treated mdx mice. HR, heart rate; PR, PR interval; QRS, QRS duration; QTc, heart rate-corrected QT interval; Q Amp, Q amplitude in lead I; C. Index, cardiomyopathy index.

Article Snippet: Beats from a continuous 1-min recording were averaged to generate a signal-averaged ECG for analysis with Chart ECG analysis software (version 2.0; ADInstruments).

Techniques: